medline.ch ORL Hals

	In vitro and in silico studies of anticancer activities of pectic acid and pectin oligosaccharide in Epstein-Barr virus-positive nasopharyngeal carcinoma. J Comput Aided Mol Des Mohan D, Khor BK, Murugaiyah V, Teh AH, Yap BK. PMID: 41460354 [PubMed - indexed for MEDLINE]
	Dosimetric Determinants of Locoregional Failure in Nasopharyngeal Carcinoma Treated with Definitive Intensity-modulated Radiotherapy (IMRT) with or without Concomitant Chemotherapy. Asian Pac J Cancer Prev Kalantari Khandani M, Javadinia SA, Nouri M. PMID: 41459851 [PubMed - indexed for MEDLINE]
	Nasopharyngeal Carcinoma in Southeast Asia: Current Landscape and Future Priorities. Br J Biomed Sci Chan SM, Paterson IC, Yap LF. PMID: 41459134 [PubMed - indexed for MEDLINE]
	Machine learning-based integration of radiomics and dosiomics for early prediction of radiation-induced temporal lobe injury in nasopharyngeal carcinoma: A multicenter study. J Appl Clin Med Phys Sun X, Zhu H, Qiao J, Liang Y, Zhu Z, Dong S, Wang J. PMID: 41456601 [PubMed - indexed for MEDLINE]
	Epigenomic landscape of nasopharyngeal carcinoma. Med Oncol Silmi Almohammadin SS, S M N Mydin RB, Bahar R, Sivasamy D, Musa MY. PMID: 41452386 [PubMed - indexed for MEDLINE]
	Diagnostic Value of Epstein-Barr Virus Immunofluorescence and Enzyme-Immunoassay Platforms for Detecting IgA Antibodies in Nasopharyngeal Carcinoma in the Singaporean Cohort. J Med Virol Ng SH, Huang W, Seng EH, Ng Q, Yang Q, Thean SM, Ng WC, Loh KS, Tay JK, Lim CM, Wan WY. PMID: 41439796 [PubMed - indexed for MEDLINE]
	NPC-SurvAI: A fully automated deep learning framework for prognostic prediction and risk stratification in patients with nasopharyngeal carcinoma. Radiother Oncol You J, Ou H, Zhang Y, Wu X, Zhang L, Jin Z, Chen Q, Shen H, Liu X, Sun J, Zhao H, Luo C, Zhang S, Zhang B. PMID: 41429722 [PubMed - indexed for MEDLINE]
	Immune archetypes TIME classification system for nasopharyngeal carcinoma: A new direction for precision immunotherapy. Biochim Biophys Acta Rev Cancer Lu F, Bai X, Lv Z, Zhang W. PMID: 41429718 [PubMed - indexed for MEDLINE]
	Research progress on the regulation of ferroptosis in NPC (Review). Oncol Rep Bai S, Guo Y, Qiang J, Dai Q, Yang Y. PMID: 41416424 [PubMed - indexed for MEDLINE]
	Discontinuation of immunotherapy and its effect on prognosis in recurrent or metastatic nasopharyngeal carcinoma patients: a retrospective analysis. Cancer Immunol Immunother Peng Y, Chu X, Zha D, Meng L, Yao J, Liu T, Liu Q, Xu X, Wang S, Chen M, You R, Liu Y. PMID: 41410705 [PubMed - indexed for MEDLINE]
	Anlotinib monotherapy in recurrent or metastatic nasopharyngeal carcinoma: a multicenter case-series analysis. Radiol Oncol Qin GJ, Su YX, Liang Y, Zhang B, Pan YF, Lu JX, Xie YY, Dai JX, Chen KQ, Qin FF, Yang HY, Kong XY, Xie Y, Ruan XL, Mo YY, Zhang RY, Zhang J, Jiang W. PMID: 41401065 [PubMed - indexed for MEDLINE]
	Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma. Clin Transl Med Hou Z, Feng P, Chiang CL, Islam KA, Liu S, Wang Y, Zhang Y, Chung MK, Kam NW, Huang Z, Lee VH, Lee AW, Kwong DL, Ng WT, Wong JWH, Xia Y, Dai W. PMID: 41397929 [PubMed - indexed for MEDLINE]
	Machine learning-based prediction of nasopharyngeal carcinoma risk: a clinical approach. Front Immunol Yang W, Zhou C, Tang M, Huang Z, Zhu H, Li S, Huang H, Liang Y, Pan W, Yuan Y. PMID: 41394826 [PubMed - indexed for MEDLINE]
	S-1 maintenance chemotherapy following definitive chemoradiotherapy in high-risk locally advanced nasopharyngeal carcinoma: a propensity score-matched analysis. Front Immunol Zuo Q, Jia J, Liu R, Zhao J, Wu H, Chen J, Duan H, Yang Z, Shi J, Yang Q, Li F, Xiang Z, Huang C, Xiong L, Yang Z. PMID: 41383583 [PubMed - indexed for MEDLINE]
	Targeting Ferroptosis in Nasopharyngeal Carcinoma: Mechanisms, Resistance, and Precision Therapeutic Opportunities. Int J Mol Sci Lee J, Roh JL. PMID: 41373599 [PubMed - indexed for MEDLINE]
	Outcomes and recurrence pattern analysis of intensity modulated chemoradiotherapy in nasopharyngeal cancer: a retrospective study from Heidelberg University Hospital. Radiat Oncol Bauer L, Regnery S, Deng MY, Stritzke F, Schröter P, Franke H, Netzer NB, Uzun-Lang K, Weusthof K, Thoelken R, Debus J, Held T. PMID: 41361781 [PubMed - indexed for MEDLINE]
	Efficacy of metastasis-directed therapy in de novo metastatic nasopharyngeal carcinoma patients receiving chemo-immunotherapy and local regional radiotherapy: a multicenter retrospective study. BMC Cancer He SQ, Lv SH, Wen SQ, Wang L, Yu YH, Zhang GY, Peng DS, Bei WX, Chen CL, Zhao ZY, Huang Y, Xiang YQ, Liu GY. PMID: 41331414 [PubMed - indexed for MEDLINE]
	Machine Learning Accelerates Discovery of High-Performance Corrole Photosensitizers for Optical Imaging Diagnosis and Photodynamic Therapeutics of Nasopharyngeal Carcinoma. J Phys Chem Lett Huang K, Yang Y, Huang H, Tang Y, Han W, Huang J, An Y, Yin J. PMID: 41319335 [PubMed - indexed for MEDLINE]
	Positioning accuracy and dosimetric evaluation of customized immobilization for FBCT guided VMAT in nasopharyngeal carcinoma. Sci Rep Chen X, Huang X, Wang Y, Diao W, Jia L, Li H, Xie D, Chen A, Jiang X. PMID: 41309761 [PubMed - indexed for MEDLINE]
	Risk factors and clinical prediction model for vertebral artery stenosis following radiotherapy for nasopharyngeal carcinoma. J Int Med Res Zhou J, Ying L, Hui Y, Zhuohua X, Mingjing W, Xiaodong Z. PMID: 41309048 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 8934

Seite 1 von 447

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung